ニュース

Science communication, together with creativity, ensures that information is both accurate and accessible. In order to ...
The agreement between BioNTech’s subsidiary BioNTech UK and the UK government is focused on accelerating clinical trials for ...
Olaparib tablets, marketed under the brand name Lynparza, are already available on the NHS for certain breast cancer ...
Medscape Oncology is making a powerful impact at ASCO 2025, bringing seven high-impact symposia, new research insights, and ...
Regeneron Pharmaceuticals has announced that it will be acquiring human genetics and biotechnology company 23andMe for $256m.
AstraZeneca (AZ) has shared positive results from a phase 3b study of its anti-inflammatory reliever rescue therapy Airsupra ...
In exchange, 3SBio will receive $1.25bn upfront from Pfizer and will be eligible for certain development, regulatory and ...
VML France has announced the appointment of Philippe Huot-Louradour as director of VML Health France. Hout, who has also been ...
The US Food and Drug Administration (FDA) has approved Fujirebio Diagnostics’ Alzheimer’s disease (AD) blood test to help ...
Merck & Co – known as MSD outside of the US and Canada – has announced that its Welireg (belzutifan) has been approved by the ...
Medscape Education is proud to announce the presentation of eight innovative educational research publications at the ...
MSD – known as Merck & Co in the US and Canada – has received approval from the Medicines and Healthcare products Regulatory ...